Ancora Advisors, LLC Pacira Bio Sciences, Inc. Transaction History
Ancora Advisors, LLC
- $4.06 Billion
- Q1 2025
A detailed history of Ancora Advisors, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Ancora Advisors, LLC holds 4,400 shares of PCRX stock, worth $110,792. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,400
Previous 1,400
214.29%
Holding current value
$110,792
Previous $26,000
319.23%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PCRX
# of Institutions
260Shares Held
51MCall Options Held
157KPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$202 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.24MShares$132 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$57 Million0.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.24MShares$56.4 Million0.09% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.05MShares$51.6 Million0.01% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.15B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...